Literature DB >> 18497882

Overindulgence and metabolic syndrome: is FoxO1 a missing link?

Janet D Sparks1, Charles E Sparks.   

Abstract

Excessive production of triglyceride-rich VLDL, which can result from dietary overindulgence, underlies metabolic syndrome--a combination of disorders including high blood pressure, obesity, high triglyceride, and insulin resistance--and places individuals at increased risk of developing cardiovascular disease and type 2 diabetes. However, the link between VLDL overproduction and insulin resistance has remained unclear. VLDL assembly in the liver is catalyzed by microsomal triglyceride transfer protein (MTP). In this issue of the JCI, Kamagate et al. investigate the events controlling hepatic MTP expression and VLDL production and secretion (see the related article beginning on page 2347). They demonstrate that MTP is a target of the transcription factor FoxO1 and that excessive VLDL production associated with insulin resistance is caused by the inability of insulin to regulate FoxO1 transcriptional activation of MTP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18497882      PMCID: PMC2391069          DOI: 10.1172/JCI35693

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  18 in total

Review 1.  SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver.

Authors:  Jay D Horton; Joseph L Goldstein; Michael S Brown
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

Review 2.  The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation.

Authors:  Lars P Van Der Heide; Marco F M Hoekman; Marten P Smidt
Journal:  Biochem J       Date:  2004-06-01       Impact factor: 3.857

3.  Regulation of microsomal triglyceride transfer protein gene by insulin in HepG2 cells: roles of MAPKerk and MAPKp38.

Authors:  Wo-Shing Au; Hsiang-fu Kung; Marie C Lin
Journal:  Diabetes       Date:  2003-05       Impact factor: 9.461

4.  Altered triglyceride-rich lipoprotein production in Zucker diabetic fatty rats.

Authors:  Doru V Chirieac; Heidi L Collins; Joanne Cianci; Janet D Sparks; Charles E Sparks
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-02-17       Impact factor: 4.310

5.  Insulin regulates hepatic apolipoprotein B production independent of the mass or activity of Akt1/PKBalpha.

Authors:  Crystal S Au; Amy Wagner; Taryne Chong; Wei Qiu; Janet D Sparks; Khosrow Adeli
Journal:  Metabolism       Date:  2004-02       Impact factor: 8.694

6.  FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice.

Authors:  Adama Kamagate; Shen Qu; German Perdomo; Dongming Su; Dae Hyun Kim; Sandra Slusher; Marcia Meseck; H Henry Dong
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

7.  A deficiency of microsomal triglyceride transfer protein reduces apolipoprotein B secretion.

Authors:  G K Leung; M M Véniant; S K Kim; C H Zlot; M Raabe; J Björkegren; R A Neese; M K Hellerstein; S G Young
Journal:  J Biol Chem       Date:  2000-03-17       Impact factor: 5.157

Review 8.  Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly.

Authors:  M Mahmood Hussain; Jason Shi; Paul Dreizen
Journal:  J Lipid Res       Date:  2003-01       Impact factor: 5.922

9.  Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production.

Authors:  Meihui Pan; Arthur I Cederbaum; Yuan-Li Zhang; Henry N Ginsberg; Kevin Jon Williams; Edward A Fisher
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

Review 10.  Synthesis and function of hepatic very-low-density lipoprotein.

Authors:  G F Gibbons; D Wiggins; A-M Brown; A-M Hebbachi
Journal:  Biochem Soc Trans       Date:  2004-02       Impact factor: 5.407

View more
  18 in total

1.  FoxO1 links hepatic insulin action to endoplasmic reticulum stress.

Authors:  Adama Kamagate; Dae Hyun Kim; Ting Zhang; Sandra Slusher; Roberto Gramignoli; Stephen C Strom; Suzanne Bertera; Steven Ringquist; H Henry Dong
Journal:  Endocrinology       Date:  2010-05-25       Impact factor: 4.736

Review 2.  Hepatic ABCA1 and VLDL triglyceride production.

Authors:  Mingxia Liu; Soonkyu Chung; Gregory S Shelness; John S Parks
Journal:  Biochim Biophys Acta       Date:  2011-10-06

3.  FoxO1 and hepatic lipid metabolism.

Authors:  Janet D Sparks; Henry H Dong
Journal:  Curr Opin Lipidol       Date:  2009-06       Impact factor: 4.776

4.  Acute suppression of apo B secretion by insulin occurs independently of MTP.

Authors:  Janet D Sparks; Jeffrey M Chamberlain; Colleen O'Dell; Irani Khatun; M Mahmood Hussain; Charles E Sparks
Journal:  Biochem Biophys Res Commun       Date:  2011-02-18       Impact factor: 3.575

Review 5.  Genetic determinants of cardiometabolic risk: a proposed model for phenotype association and interaction.

Authors:  Piers R Blackett; Dharambir K Sanghera
Journal:  J Clin Lipidol       Date:  2012-04-22       Impact factor: 4.766

Review 6.  The ever-expanding role of degradation in the regulation of apolipoprotein B metabolism.

Authors:  Henry N Ginsberg; Edward A Fisher
Journal:  J Lipid Res       Date:  2008-12-02       Impact factor: 5.922

Review 7.  The many intersecting pathways underlying apolipoprotein B secretion and degradation.

Authors:  Jeffrey L Brodsky; Edward A Fisher
Journal:  Trends Endocrinol Metab       Date:  2008-08-06       Impact factor: 12.015

8.  Insulin-dependent apolipoprotein B degradation is mediated by autophagy and involves class I and class III phosphatidylinositide 3-kinases.

Authors:  Janet D Sparks; Colleen O'Dell; Jeffrey M Chamberlain; Charles E Sparks
Journal:  Biochem Biophys Res Commun       Date:  2013-05-15       Impact factor: 3.575

Review 9.  Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis.

Authors:  Wen-Lung Ma; Hsueh-Chou Lai; Shuyuan Yeh; Xiujun Cai; Chawnshang Chang
Journal:  Endocr Relat Cancer       Date:  2014-05-06       Impact factor: 5.678

10.  Old and rising stars in the lymphoid liver.

Authors:  Carlo Selmi; Mauro Podda; M Eric Gershwin
Journal:  Semin Immunopathol       Date:  2009-07-15       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.